US Archives - Page 116 of 173 - European Medical Journal

Lung Cancer Screening: Comorbidity and Diversity Challenges Revealed

A recent cohort study has highlighted significant disparities in comorbidity profiles among patients undergoing low-dose computed tomography (LDCT) for lung cancer screening.

Menthol Cigarettes Carry Higher Mortality Risk Compared to Non-Menthol

Smoking menthol-flavored cigarettes is associated with higher mortality risks compared to non-menthol cigarettes according to a new study.

Managing PTLD in Pediatric Liver Transplants

The significant concern of Epstein-Barr virus (EBV) in pediatric liver transplant recipients due to its strong association with post-transplant lymphoproliferative disorder (PTLD) has been explored in a recently published study.

RA Drugs Show Promise Despite Kidney Issues

Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.

Dupilumab Shows Cardiometabolic Benefits in Atopic Dermatitis

A recent global retrospective cohort study has demonstrated that dupilumab, a monoclonal antibody used to treat atopic dermatitis (AD), offers a favorable cardiometabolic safety profile compared to traditional systemic agents such as methotrexate and cyclosporine.

Tramadol and Parkinson’s: New Pain Insights

Patients with Parkinson’s disease (PD) are five times more likely to experience chronic pain than their age-matched peers, according to a new study analyzing electronic medical records from over 250 million patients.

Integrative Sleep Medicine Enhances Cancer Care: MCM 2025

Integrative sleep medicine is revolutionizing cancer care, as highlighted at the 21st Annual Miami Cancer Meeting (MCM) in Tampa, Florida, this January.

New mRNA Vaccine Boosts TB Protection

A novel lipid nanoparticle (LNP)-mRNA vaccine has demonstrated strong immune responses and enhanced protection against Mycobacterium tuberculosis, the leading cause of infectious mortality worldwide.

Hydrogel Treatment for Atopic Dermatitis Receives FDA Clearance

The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for Zabalafin Hydrogel, a novel therapy designed to treat mild to moderate atopic dermatitis (AD) comprehensively.

MMR Boosters Show Weak Long-Term Immunity

Concerns about the effectiveness of multiple MMR vaccine booster doses in individuals who remain seronegative after the standard two-dose schedule have been highlighted in a new study.